Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume & ASP by Product, Application & End-users The global remote patient monitoring devices market will witness a robust CAGR of 18%, valued at $5 billion in 2023, expected to appreciate and reach $16.7 billion by 2030, confirms Strategic Market Research. North America held the largest industry size, with 41.67% of the total market for remote patient monitoring. Remote patient monitoring (RPM) is a type of healthcare delivery that employs the latest developments in information technology to gather patient data outside of traditional healthcare facilities. It is also known as remote monitoring telemedicine. The earliest record of remote patient monitoring began in the 1800s when two physicians were reported to have consulted. In 1948, a doctor sent x-ray images to another doctor through telephone wires in Pennsylvania. Neurological examinations were transmitted in 1959 electronically, while psychological consultations were transmitted through closed-circuit television in 1960. With the growing adoption of the internet in the 1990s, old-school telemedicine evolved into a newer form of remote patient monitoring that is well-known today. Remote patient monitoring has been beneficial to both patients and clinicians. It has reduced the risk of disease transmission, freed up limited hospital resources, enabled faster access to patient data, improved patient outcomes, and improved cost savings for healthcare providers. Remote patient monitoring has increased rapidly due to COVID-19 and is expected to increase further at a higher rate. According to various studies, 23.4 million US patients used various remote patient monitoring tools in 2020, and the number of patients using these tools is expected to rise by 28.2% to 30 million US patients by 2024. Key Industry Drivers - Increasing Number of Chronic Complaints and Increasing Need to Expand Healthcare Access The number of people suffering from NCD or chronic diseases like cancer is increasing, which causes the demand for remote patient monitoring to grow. As per the CDC, about 660,000 people in the United States of America die from heart disease every year, while according to the NICHD, around 140,000 Americans die from stroke every year. The rising number of patients with chronic complaints stresses the need for remote monitoring, which causes the positive shift of remote patient monitoring devices market trends. Governments of developed and developing countries understand the need to expand healthcare access to their population. According to an NCBI study, 3.6 million Americans miss at least one appointment due to transportation issues. Around 54% of children who missed proper health care lived in metro areas with 1 million or more populations. This drives the need to make healthcare infrastructure more accessible, thereby increasing market growth. Restraints - Healthcare Fraud, High Costs fraud is a major concern in the telehealth industry. According to the United States Sentencing Commission (USSC), in the fiscal year 2020, there were 330 healthcare fraudsters, which accounted for 7.7% of all theft, property destruction, and fraud offenses in the USA. The rising healthcare fraud cases cause many patients to physically visit hospitals, hindering industry growth. High costs of remote patient monitoring devices force the patients to visit the hospitals more often. This might force the government to cut costs in healthcare which can impede market growth. Opportunities - High utility of RPM to Combat Infectious Diseases and Epidemics The increasing demand for remote patient monitoring (RPM) to combat infectious diseases and epidemics like COVID-19 can improve market growth. Newer technological developments can fully leverage the demand for RPM. Devices like Blood pressure monitor, Weight monitor, Patient wearables, Blood glucose monitor, Spirometer, ECG + Stethoscope, Thermometer, Bluetooth scales, Anticoagulation testing device, Electrocardiography (ECG) devices, Heart rate monitors, medical alert systems, peak flow monitors, blood pressure cuff, pulse oximeter, and glucometer can be used for Cellular Remote Patient Monitoring, Maternity care monitoring, Paediatric at-home monitoring, Medication monitoring, Bluetooth Remote Patient Monitoring, Hypertension management, Medication management and titration, Weight measurement for congestive heart failure, Weight measurement for obesity, Pulmonology Remote Patient Monitoring, COPD management, Asthma management, Other respiratory disease management, Endocrinology Remote Patient Monitoring, Glucose monitoring, and Continuous Glucose Monitoring to monitor rising cases of diseases like Cancer, COVID-19, Dementia and falls, Diabetes, Chronic Obstructive Pulmonary Disease, Dementia and falls, Diabetes, Congestive heart failure, and infertility. According to the World Health Organization, 55 million people will have dementia in 2021, and 10 million new dementia cases are reported annually. The number of people with dementia is expected to rise to 78 million in 2030 and 139 million in 2050. This could increase remote patient monitoring adoption, which could foster industry growth. Market Analysis Of Different Segments Covered in the Report Based on Product Sign Monitors Monitors Monitoring Devices Monitoring Devices Systems Monitoring Devices Function Monitoring Devices Devices Monitors Based on End-Use Hospital-based Patients Homecare Ambulatory Patients Based on Application Disorder Management Monitoring Diseases Bronchitis Regional Coverage Analysis North America United States of America Canada Europe United Kingdom Germany France Italy Spain Rest of Europe Asia-Pacific Japan India China Thailand South Korea Rest of Asia-Pacific Latin America Mexico Brazil Argentina Colombia Rest of Latin America The Middle East and Africa South Africa Saudi Arabia United Arab Emirates Rest of the Middle East and Africa Segments Analysis & Insights The vital signs monitor segment held the largest remote patient monitoring market in 2021, with around 38.89%. The vital signs monitor segment is also expected to be the fastest-growing remote patient monitoring devices market, with a 21.9% CAGR. The rise in the number of patients with heart disorders causes an increased demand for vital sign monitors. According to the British Heart Foundation, nearly 7.6 million people in the UK live with a heart or circulatory disease; 4 million men and 3.6 million women suffer from these diseases. The ‘hospital-based patients’ segment held the highest market for remote patient monitoring devices, with 79.4% in 2021. Hospitals offer many diagnostic tests and appoint many technical staff to cater to patients’ needs. According to an American Cancer Society Journal, there were an estimated 1.9 million new cancer cases in 2021, an approximately 6% increase from 1.786 million new cancer cases reported in 2020. This caused the market to grow, although it is expected to slow down due to the high costs of hospital admissions and stringent reimbursement procedures. The diabetes segment had the highest market size, with 12.8% of the total industry share. Diabetes emerged as one of the leading causes of death. According to the International Diabetes Federation, 51 million adults, or 1 in 7 adults, live with diabetes in North America. This number is expected to rise to 57 million by 2030 and 63 million by 2045. The rising number of diabetes cases drove the need for remote patient monitoring devices, fostering industry growth. North America held the largest remote patient monitoring devices market size, with 41.67% of the total market for remote patient monitoring. The surge in the frequency of chronic diseases, increasing investment in R&D, and the demand for portable and wireless systems coupled with sophisticated reimbursement policies aimed to reduce huge pocket expenditures drove the growth of this industry segment. According to the American Sleep Association, 50 to 70 million US adults have a sleep disorder, while according to the CDC, nearly 47% of all US adults suffer from hypertension. The Asia-Pacific region will be the fastest-growing industry, with a CAGR of 14.39%. The region’s vast untapped opportunities and rising incidence of chronic diseases fostered market growth. According to the National Health Commission of China, about 73% of Chinese suffer from sleep disorders, while according to the WHO, nearly 270 million Chinese have hypertension. Remote Patient Monitoring Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2023 USD 5 billion The revenue forecast in 2030 USD 16.7 billion Growth rate CAGR of approximately 18% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Application, By End-Use, and By Region By Product Vital Sign Monitors, Cardiac Monitors, Respiratory Monitoring Devices, Haematological Monitoring Devices, Anaesthesia Systems Monitoring Devices, Renal Function Monitoring Devices, Telemetry Devices, Multi-parameter Monitors, Others By Application Cancer, Diabetes, Hypertension, Sleep Disorder and Fitness Monitoring, Bronchitis, Infections, Cardiovascular Diseases, Virus, and Weight Management. By End-Use Hospital-based patients, Home care patients, Ambulatory patients By Region Asia-Pacific, North America, Europe, Latin America, the Middle East, and Africa Country Scope United States of America, Mexico, United Kingdom, Germany, France, Italy, Spain, Canada, Japan, India, China, Thailand, South Korea, Brazil, Argentina, Colombia, South Africa, Saudi Arabia, United Arab Emirates Company Usability Profiles Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Nihon Omron Corporation, OSI Systems, Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd, Smiths Medical, Kohden Corporation, Masimo, Welch Allyn, Boston Scientific Corporation, Dräger Medical, Honeywell, LifeWatch, Medtronic, Vitls, Inc., CareValidate, Biotronik, GE Healthcare, Johnson & Johnson, Cerner Corporation Telecare. Global Remote Patient Monitoring Devices Market Competitive Landscape Analysis The industry is moderately fragmented. The industry is highly competitive, and companies adopt different strategies like mergers & acquisitions, partnerships, and collaborations to maintain their industry share. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Smiths Medical Nihon Kohden Corporation Koninklijke Philips N.V. Omron Corporation F. Hoffmann-La Roche Ltd American Telecare Welch Ally OSI Systems, Inc. Boston Scientific Corporation GE Healthcare Johnson & Johnson Dräger Medical Masimo Vitls, Inc Abbott CareValidate Biotronik LifeWatch Cerner Corporation Honeywell Recent Developments January 2022, OMRON Healthcare, Inc. won the best of honors for remote patient monitoring programs in the United States of America and the United Kingdom. OMRON Healthcare believes that the recognition will help it foster greater active health care management, guide behavioral change to reduce health risks, strengthen the patient-physician connection, and advance the company’s mission of Going for Zero, the complete elimination of stroke and heart attack. In September 2021, Medtronic announced its partnership with Stasis Health to promote Stasis’ new bedside patient monitoring system in India. The companies believe that the collaboration will help Stasis enlarge its medical presence in the country while enhancing Medtronic’s position in the remote patient monitoring market. December 2020, Cerner Corporation announced that it was building on its collaboration with Xealth to offer health systems new centralized digital monitoring and ordering. With the new offerings, Cerner believes that health centers can have a more holistic view of their digital health solutions, meet increasing demands for telehealth, and offer remote patient monitoring. July 2020, Koninklijke Philips NV announced a collaboration with BioIntellisense to integrate its BioSticker medical device into Philips’ remote patient monitoring system. Philips and BioIntellisense believe that the strategic collaboration will offer clinical specialists to help monitor at-risk patients from the hospital to home. April 2020, GE Healthcare deployed its remote patient data monitoring technology, the Mural Virtual Care Solution, to support clinicians and health systems in COVID-19 treatment. GE Healthcare believes introducing the software will help ease the burden by enabling clinical surveillance of ICU patients in a central system, giving healthcare professionals a comprehensive view of each patient’s data across the hospital network. Various Devices and Systems that Key Market Leaders Develop: Device Function Key Player BioButton Collection of physiological data BioIntellisense DexCom G6 CGM System Remote Monitoring of Type 1 and Type 2 Diabetes DexCom, Inc eCareCoordinator Telehealth Koninklijke Philips NV Solo Virtual Care Platform Telehealth Teladoc OnePulse Smartwatch Measures physiological data of an individual and warns doctors and family members of unusual activity OneLife Technologies Corporation Frequently Asked Question About This Report What is remote patient monitoring system market growth? The remote patient monitoring system market is expected to grow at 12.1% CAGR. What is the projected global indusrty in 2030? The global indusrty’s projected value in 2030 will be USD 4.07 billion. What is remote monitoring telemedicine? Remote monitoring telemedicine is a type of healthcare delivery that employs the latest developments in information technology to gather patient data outside of traditional healthcare facilities. How big is the remote patient monitoring system market? The remote patient monitoring system market is valued at USD 1.45 billion in 2021 and is estimated to reach $4.07 Billion by 2030, representing a CAGR of 8.74% throughout the forecasted period of 2021-2030. Who are the main competitors in the global indusrty? The leading players in the global indusrty are Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Omron Corporation, Nihon Kohden Corporation, OSI Systems, Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd, Dräger Medical, Welch Allyn, Smiths Medical, Abbott, Boston Scientific Corporation, GE Healthcare, Honeywell, Johnson & Johnson, LifeWatch, Masimo, Medtronic, Vitls, Inc., CareValidate, Biotronik, American Telecare, and Cerner Corporation. What are the major drivers in the global indusrty report? The key trends in the global indusrty growth are the increasing number of chronic complaints and the Increasing need to expand healthcare access. Sources https://www.nichd.nih.gov/health/topics/stroke/conditioninfo/risk https://www.who.int/news-room/fact-sheets/detail/dementia https://www.bhf.org.uk/what-we-do/news-from-the-bhf/contact-the-press-office/facts-and-figures https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2021.html https://blog.prevounce.com/27-remote-patient-monitoring-statistics-every-practice-should-know https://www.cancer.gov/about-nci/budget/fact-book/data/research-funding 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at Market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Remote Patient Monitoring Devices Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Remote Patient Monitoring Devices Market 4.2.1 Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, by region, 2021 - 2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 Market, By Product, 2021 - 2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 Market, By End-User, 2021 - 2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Market, By Application, 2021 - 2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9Business Environment Analysis Tool 4.9.1 Market PEST analysis 4.9.2 Market Porter’s analysis 4.10Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2021) 5.11.2. Trends in Application (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Vital Sign Monitors 7.3.1. Vital Sign Monitors, 2021 - 2030 (USD Million) 7.4. Cardiac Monitors 7.4.1. Cardiac Monitors Market, 2021 - 2030 (USD Million) 7.5. Haematological Monitoring Devices 7.5.1. Haematological Monitoring Devices Market, 2021 - 2030 (USD Million) 7.6. Anaesthesia Systems Monitoring Devices 7.6.1. Anaesthesia Systems Monitoring Devices Market, 2021 - 2030 (USD Million) 7.7. Renal Function Monitoring Devices 7.7.1. Renal Function Monitoring Devices Market, 2021 - 2030 (USD Million) 7.8. Telemetry Devices 7.8.1. Telemetry Devices Market, 2021 - 2030 (USD Million) 7.9. Multi-parameter Monitors 7.9.1. Multi-parameter Monitors Market, 2021 - 2030 (USD Million) 7.10. Others 7.10.1. Others Market, 2021 - 2030 (USD Million) 8. Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospital-based patients 8.3.1. Hospital-based patients Market, 2021 - 2030 (USD Million) 8.4. Home care patients 8.4.1. Home care patients Market, 2021 - 2030 (USD Million) 8.5. Ambulatory patients 8.5.1. Ambulatory patients Market, 2021 - 2030 (USD Million) 9. Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Cancer 9.3.1. Cancer Market, 2021 - 2030 (USD Million) 9.4. Diabetes 9.4.1. Diabetes Market, 2021 - 2030 (USD Million) 9.5. Sleep Disorder 9.5.1. Sleep Disorder Market, 2021 - 2030 (USD Million) 10. Market: Regional Outlook 10.1 North America 10.1.1. North America Market, By Product, 2021 - 2030 (USD Million) 10.1.2. North America Market, By End-User, 2021 - 2030 (USD Million) 10.1.3. North America Market, by Application, 2021 - 2030 (USD Million) 10.1.4. North America Market, by Country, 2021 - 2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. Market, By Product, 2021 - 2030 (USD Million) 10.1.4.1.2. U.S. Market, By End-User, 2021 - 2030 (USD Million) 10.1.4.1.3. U.S. Market, by Application, 2021 - 2030 (USD Million) 10.1.4.2. Canada 10.1.4.2.1. Canada Market, By Product, 2021 - 2030 (USD Million) 10.1.4.2.2. Canada Market, By End-User, 2021 - 2030 (USD Million) 10.1.4.2.3. Canada Market, by Application, 2021 - 2030 (USD Million) 10.2. Europe 10.2.1. Europe Market, By Product, 2021 - 2030 (USD Million) 10.2.2. Europe Market, By End-User, 2021 - 2030 (USD Million) 10.2.3. Europe Market, by Application, 2021 - 2030 (USD Million) 10.2.4. Europe Market, by country, 2021 - 2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. Market, By Product, 2021 - 2030 (USD Million) 10.2.4.1.2. U.K. Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.1.3. U.K. Market, by Application, 2021 - 2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany Market, By Product, 2021 - 2030 (USD Million) 10.2.4.2.2. Germany Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.2.3. Germany Market, by Application, 2021 - 2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France Market, By Product, 2021 - 2030 (USD Million) 10.2.4.3.2. France Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.3.3. France Market, by Application, 2021 - 2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe Market, By Product, 2021 - 2030 (USD Million) 10.2.4.4.2. Rest of Europe Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.4.3. Rest of Europe Market, by Application, 2021 - 2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific Market, By Product, 2021 - 2030 (USD Million) 10.3.2. Asia Pacific Market, By End-User, 2021 - 2030 (USD Million) 10.3.3. Asia Pacific Market, by Application, 2021 - 2030 (USD Million) 10.3.4. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China Market, By Product, 2021 - 2030 (USD Million) 10.3.4.1.2. China Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.1.3. China Market, by Application, 2021 - 2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India Market, By Product, 2021 - 2030 (USD Million) 10.3.4.2.2. India Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.2.3. India Market, by Application, 2021 - 2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan Market, By Product, 2021 - 2030 (USD Million) 10.3.4.3.2. Japan Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.3.3. Japan Market, by Application, 2021 - 2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea Market, By Product, 2021 - 2030 (USD Million) 10.3.4.4.2. South Korea Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.4.3. South Korea Market, by Application, 2021 - 2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC Market, By Product, 2021 - 2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC Market, by Application, 2021 - 2030 (USD Million) 10.4. Latin America 10.4.1. Latin America Market, By Product, 2021 - 2030 (USD Million) 10.4.2. Latin America Market, By End-User, 2021 - 2030 (USD Million) 10.4.3. Latin America Market, by Application, 2021 - 2030 (USD Million) 10.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil Market, By Product, 2021 - 2030 (USD Million) 10.4.4.1.2. Brazil Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.1.3. Brazil Market, by Application, 2021 - 2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico Market, By Product, 2021 - 2030 (USD Million) 10.4.4.2.2. Mexico Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.2.3. Mexico Market, by Application, 2021 - 2030 (USD Million) 10.4.4.3. Rest of Latin America 10.4.4.3.1. Rest of the Latin America Market, By Product, 2021 - 2030 (USD Million) 10.4.4.3.2. Rest of the Latin America Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.3.3. Rest of the Latin America Market, by Application, 2021 - 2030 (USD Million) 10.5. MEA 10.5.1. MEA Market, By Product, 2021 - 2030 (USD Million) 10.5.2. MEA Market, By End-User, 2021 - 2030 (USD Million) 10.5.3. MEA Market, by Application, 2021 - 2030 (USD Million) 10.5.4. MEA Market, by Region, 2021 - 2030 (USD Million) 11. Competitive Landscape 11.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. ProductPortfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. MASIMO 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. NIHON KOHDEN CORPORATION 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. KONINKLIJKE PHILIPS N.V 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. OMRON CORPORATION 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. F. Hoffmann-La Roche Ltd 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. American Telecare 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. Welch Ally 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. OSI Systems, Inc. 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. Boston Scientific Corporation 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. GE Healthcare 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. Johnson & Johnson 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development 11.13. Dräger Medical 11.13.1. Company overview 11.13.2. Financial performance 11.13.3. Product Portfolio Analysis 11.13.4. Business Strategy & Recent Development 11.14. Masimo 11.14.1. Company overview 11.14.2. Financial performance 11.14.3. Product Portfolio Analysis 11.14.4. Business Strategy & Recent Development 11.15. Vitls, Inc 11.15.1. Company overview 11.15.2. Financial performance 11.15.3. Product Portfolio Analysis 11.15.4. Business Strategy & Recent Development 11.16. Abbott 11.16.1. Company overview 11.16.2. Financial performance 11.16.3. Product Portfolio Analysis 11.16.4. Business Strategy & Recent Development 11.17. CareValidate 11.17.1. Company overview 11.17.2. Financial performance 11.17.3. Product Portfolio Analysis 11.17.4. Business Strategy & Recent Development 11.18. Biotronik 11.18.1. Company overview 11.18.2. Financial performance 11.18.3. Product Portfolio Analysis 11.18.4. Business Strategy & Recent Development 11.19. LifeWatch 11.19.1. Company overview 11.19.2. Financial performance 11.19.3. Product Portfolio Analysis 11.19.4. Business Strategy & Recent Development 11.20. Cerner Corporation 11.20.1. Company overview 11.20.2. Financial performance 11.20.3. Product Portfolio Analysis 11.20.4. Business Strategy & Recent Development 11.21. Honeywell 11.21.1. Company overview 11.21.2. Financial performance 11.21.3. Product Portfolio Analysis 11.21.4. Business Strategy & Recent Development List of Tables (84 Tables) TABLE 1. Market, By Product, 2021-2030 (USD Million) TABLE 2. Market FOR Vital Sign Monitors, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Cardiac Monitors, BY REGION, 2021-2030 (USD Million) TABLE 4. Market FOR Respiratory Monitoring Devices, BY REGION, 2021-2030 (USD Million) TABLE 5. Market FOR Haematological Monitoring Devices, BY REGION, 2021-2030 (USD Million) TABLE 6. Market FOR Anaesthesia Systems Monitoring Devices, BY REGION, 2021-2030 (USD Million) TABLE 7. Market FOR Renal Function Monitoring Devices, BY REGION, 2021-2030 (USD Million) TABLE 8. Market FOR Telemetry Devices, BY REGION, 2021-2030 (USD Million) TABLE 9. Market FOR Multi-parameter Monitors, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 11. Market, By End-User, 2021-2030 (USD Million) TABLE 12. Market FOR Hospital-based patients, BY REGION, 2021-2030 (USD Million) TABLE 13. Market FOR Home care patients, BY REGION, 2021-2030 (USD Million) TABLE 14. Market FOR Ambulatory patients, BY REGION, 2021-2030 (USD Million) TABLE 15. Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 16. Market FOR Cancer, BY REGION, 2021-2030 (USD Million) TABLE 17. Market FOR Diabetes, BY REGION, 2021-2030 (USD Million) TABLE 18. Market FOR Sleep Disorder, BY REGION, 2021-2030 (USD Million) TABLE 19. Market FOR Weight Management, BY REGION, 2021-2030 (USD Million) TABLE 20. Market FOR Fitness Monitoring, BY REGION, 2021-2030 (USD Million) TABLE 21. Market FOR Cardiovascular Diseases Bronchitis, BY REGION, 2021-2030 (USD Million) TABLE 22. Market FOR Virus, BY REGION, 2021-2030 (USD Million) TABLE 23. Market FOR Dehydration, BY REGION, 2021-2030 (USD Million) TABLE 24. Market FOR Infections, BY REGION, 2021-2030 (USD Million) TABLE 25. Market FOR Hypertension, BY REGION, 2021-2030 (USD Million) TABLE 26. Market, BY REGION, 2021-2030 (USD Million) TABLE 27. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 28. NORTH AMERICA Market, By Product, 2021-2030 (USD Million) TABLE 29. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million) TABLE 30. NORTH AMERICA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 31. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 32. EUROPE Market, By Product, 2021-2030 (USD Million) TABLE 33. EUROPE Market, By End-User, 2021-2030 (USD Million) TABLE 34. EUROPE Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 35. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 36. ASIA-PACIFIC Market, By Product, 2021-2030 (USD Million) TABLE 37. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million) TABLE 38. ASIA-PACIFIC Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 39. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 40. LAMEA Market, By Product, 2021-2030 (USD Million) TABLE 41. LAMEA Market, By End-User, 2021-2030 (USD Million) TABLE 42. LAMEA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 43. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: COMPANY SNAPSHOT TABLE 44. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: OPERATING SEGMENTS TABLE 45. MASIMO: COMPANY SNAPSHOT TABLE 46. MASIMO: OPERATING SEGMENTS TABLE 47. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT TABLE 48. NIHON KOHDEN CORPORATION: OPERATING SEGMENTS TABLE 49. KONINKLIJKE PHILIPS N.V: COMPANY SNAPSHOT TABLE 50. KONINKLIJKE PHILIPS N.V: OPERATING SEGMENTS TABLE 51. OMRON CORPORATION: COMPANY SNAPSHOT TABLE 52. OMRON CORPORATION: OPERATING SEGMENTS TABLE 53. F. Hoffmann-La Roche Ltd: COMPANY SNAPSHOT TABLE 54. F. Hoffmann-La Roche Ltd: OPERATING SEGMENTS TABLE 55. American Telecare: COMPANY SNAPSHOT TABLE 56. American Telecare: OPERATING SEGMENTS TABLE 57. Welch Ally: COMPANY SNAPSHOT TABLE 58. Welch Ally: OPERATING SEGMENTS TABLE 59. OSI Systems, Inc.: COMPANY SNAPSHOT TABLE 60. OSI Systems, Inc.: OPERATING SEGMENTS TABLE 61. Boston Scientific Corporation: COMPANY SNAPSHOT TABLE 62. Boston Scientific Corporation: OPERATING SEGMENTS TABLE 63. GE Healthcare: COMPANY SNAPSHOT TABLE 64. GE Healthcare: OPERATING SEGMENTS TABLE 65. Johnson & Johnson: COMPANY SNAPSHOT TABLE 66. Johnson & Johnson: OPERATING SEGMENTS TABLE 67. Dräger Medical: COMPANY SNAPSHOT TABLE 68. Dräger Medical: OPERATING SEGMENTS TABLE 69. Masimo: COMPANY SNAPSHOT TABLE 70. Masimo: OPERATING SEGMENTS TABLE 71. Vitls, Inc: COMPANY SNAPSHOT TABLE 72. Vitls, Inc: OPERATING SEGMENTS TABLE 73. Abbott: COMPANY SNAPSHOT TABLE 74. Abbott: OPERATING SEGMENTS TABLE 75. CareValidate: COMPANY SNAPSHOT TABLE 76. CareValidate: OPERATING SEGMENTS TABLE 77. Biotronik: COMPANY SNAPSHOT TABLE 78. Biotronik: OPERATING SEGMENTS TABLE 79. LifeWatch: COMPANY SNAPSHOT TABLE 80. LifeWatch: OPERATING SEGMENTS TABLE 81. Cerner Corporation: COMPANY SNAPSHOT TABLE 82. Cerner Corporation: OPERATING SEGMENTS TABLE 83. Honeywell: COMPANY SNAPSHOT TABLE 84. Honeywell: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Remote Patient Monitoring Devices Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 21 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2021 Figure 8 Import Data for Remote Patient Monitoring Devices, By Country, 2016–2021 (USD Thousand) Figure 9 Export Data for Remote Patient Monitoring Devices, By Country, 2016–2021 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs 2025 (USD Million) Figure 12 Market Share, By Application, 2019 vs 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Vital Sign Monitors to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 16 Diabetes to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 17 Hospital-based patients to Witness Higher CAGR in the Market for End-User Segment during Forecast Period. Figure 18 North America Region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview